[Brainlife] Newsletter, Vol.1 No.3, 24 Aug 2002

top

GLIOBLASTOMA NEWSLETTER

Volume 1, Number 3 - 24 August 2002	Volume 1 Archive

Contents

	Diagnosis & Evaluation
	Prognosis & Outcome
	Treatment


Diagnosis & Evaluation

	Ehrenfeld CE, Maschke M, Dörfler A, Reinhardt V, Koeppen S Is stereotactic biopsy a reliable method to differentiate tumor from radiation necrosis? Clin Neuropathol 2002 Jan-Feb;21(1):9-12 Abstract \| Links \| BL 1:3
	V. Vallejos, C. Balaña, M. Fraile, Y. Roussos, J. Capellades, P. Cuadras, R. Ballester, A. Ley, A. Arellano, R. Rosell Use of 201Tl SPECT Imaging to Assess the Response to Therapy in Patients with High Grade Gliomas Journal of Neuro-Oncology, 59 (1): 81-90, August 2002 Abstract \| Reprint \| Links \| BL 1:3

Prognosis & Outcome

	Fadime Akman, Rachel A. Cooper, Mehmet Şen, Yildiray Tanriver, Süleyman Kentli Validation of the Medical Research Council and A Newly Developed Prognostic Index in Patients with Malignant Glioma: How useful are Prognostic Indices in Routine Clinical Practice? Journal of Neuro-Oncology, 59 (1): 39-47, August 2002 Abstract \| Reprint \| Links \| BL 1:3

Treatment

	Dora B. Bocangel, Sydney Finkelstein, S. Clifford Schold, Kishor K. Bhakat, Sankar Mitra and Demetrius M. Kokkinakis Multifaceted Resistance of Gliomas to Temozolomide Clinical Cancer Research Vol. 8, 2725-2734, 1 August 2002 Abstract \| Full Text \| Reprint \| Links \| BL 1:3
	Alba A. Brandes, Mario Ermani, Umberto Basso, Myriam K. Paris, Franco Lumachi, Franco Berti, Pietro Amistà, Marina Gardiman, Paolo Iuzzolino, Sergio Turazzi, Silvio Monfardini Temozolomide in Patients with Glioblastoma at Second Relapse after First Line Nitrosourea-Procarbazine Failure: A Phase II Study Oncology, Vol. 63, No. 1, 38-41, August2002 Abstract \| Links \| BL 1:3
	Michael S. Gordon Managing Anemia in the Cancer Patient: Old Problems, Future Solutions The Oncologist, Vol. 7, No. 4, 331-341, August 2002 Abstract \| Full Text \| Reprint \| Links \| BL 1:3
	Seigo Kinuya, MD, Atsuhiro Kawashima, MD, Kunihiko Yokoyama, MD, Kiyoshi Koshida, MD, Shota Konishi, MD, Naoto Watanabe, MD, Noriyuki Shuke, MD, Hisashi Bunko, MD, Takatoshi Michigishi, MD and Norihisa Tonami, MD Cooperative Effect of Radioimmunotherapy and Antiangiogenic Therapy with Thalidomide in Human Cancer Xenografts Journal of Nuclear Medicine Vol. 43 No. 8 1084-1089, 1 August 2002 Abstract \| Full Text \| Reprint \| Links \| BL 1:3
	Lissoni P, Meregalli S, Nosetto L, Barni S, Tancini G, Fossati V, Maestroni G Increased survival time in brain glioblastomas by a radioneuroendocrine strategy with radiotherapy plus melatonin compared to radiotherapy alone Oncology 1996 Jan-Feb;53(1):43-6 Abstract \| Links \| BL 1:3
	Lissoni P Is there a role for melatonin in supportive care? Support Care Cancer 2002 Mar;10(2):110-6 Abstract \| Links \| BL 1:3
	Pietro Riva, Giancarlo Franceschi, Massimo Frattarelli, Nada Riva, Graziano Guiducci, Anna Maria Cremonini, Graziano Giuliani, Michela Casi, Rossella Gentile, Annti A. Jekunen, Kalevi J. A. Kairemo 131I Radioconjugated Antibodies for the Locoregional Radioimmunotherapy of High-grade Malignant Glioma: Phase I and II Study Acta Oncologica, Volume 38, Number 3/May 18, 1999 Abstract \| Reprint \| Links \| BL 1:3
	E. Schuller, R. Seidl, C. Wandl, K. Dieckmann, I. Slavc Prolonged Second Response To Cisplatin, Etoposide, And Ifosfamide In A Child With A Recurrent Brainstem Glioblastoma Pediatric Hematology and Oncology, Volume 18, Number 4/June 1, 2001, 253 - 258 Abstract \| Links \| BL 1:3
	Wolfgang Wick, Mirjam Hermisson, Rolf D. Kortmann, Wilhelm M. Küker, Frank Duffner, Johannes Dichgans, Michael Bamberg, Michael Weller Neoadjuvant Gemcitabine/treosulfan Chemotherapy for Newly Diagnosed Glioblastoma Journal of Neuro-Oncology, 59 (2): 151-155, September 2002 Abstract \| Reprint \| Links \| BL 1:3

bottom